Using EST's zNOSE, CTA will conduct on-site testing of medical marijuana to insure the product is free from excessive molds, spores, insecticides and other pathogens. In addition, CTA will test the concentration of the three primary cannabinoids found in marijuana and provide the clinic with labels containing information on the strength and character of the marijuana being dispensed.

Cannabis or medical marijuana has been shown to have several well-documented beneficial effects. Among these are: the amelioration of nausea and vomiting, stimulation of hunger in chemotherapy and AIDS patients, lowered intraocular eye pressure (shown to be effective for treating glaucoma), as well as general analgesic effects (pain relief).

About Electronic Sensor Technology:

Founded in 1995, Electronic Sensor Technology has developed and patented a chemical vapor analysis process. EST's product provides near real-time analysis of gasses detecting volatile organic compounds in amounts as low as one part per trillion. EST's product has been shown to detect salmonella and e-coli contamination of food sources; chemical warfare agents such as Sarin and Agent Orange and Chemical pollutants in the environment.

About California Testing Authority

California Testing Authority LLC, (CTA) is a mobile certification and pre-screening service with a focus on the medical marijuana industry. The company offers mobile solutions for medical marijuana collectives to help meet and exceed local and state ordinance requirements. CTA provides mobile testing for potency levels of three primary cannabinoids found in marijuana: tetrohydrocannabiniol (THC), cannabidiol (CBD), and cannabiniol (CBN). In addition, safety testing is provided to detect above-average levels of molds and pathogens commonly found in medical marijuana. Our clients receive the benefit of detailed medicine bottle labels with on-the-spot printed results so collective owners can feel confident that patients are informed and public safety issues are addressed. These certified labels are rapidly becoming the standard for purchasing medical marijuana and we believe will soon become mandatory by law.

SEC Filings and Forward-Looking Statements

This press release includes forward-looking statements, including the Company's expectations regarding its ability to develop and access capital markets and its ability to achieve expected results in the chemical detection and analysis industry. The forward-looking statements are identified through use of the words "potential," "anticipate," "expect," "planned" and other words of similar meaning. These forward-looking statements may be affected by the risks and uncertainties inherent in the chemical detection and analysis industry and in the Company's business. The Company cautions readers that certain important factors may have affected and could in the future affect the Company's beliefs and expectations and could cause the actual results to differ materially from those expressed in any forward-looking statement made by or on behalf of the company.